Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Up 3.82%

Collegium Pharmaceutical reported a larger-than-expected loss per share, which typically raises concerns among investors. However, the stock rose by 3.82%, indicating that investors may have reacted positively to other aspects of the company's performance or future potential, despite the EPS miss. Without additional context from management commentary, the reasons for the stock's increase remain unclear.